KLAC
59
3
WHR
64
2
NTAP
60
2
MAC
54
3
APA
35
3
PSX
27
2
YUM
43
3
EQT
48
6
MHK
27
2
FFIV
67
3
QCOM
59
3
MKC
53
2
FRT
39
3
SRE
47
7
DOV
50
2
FAST
44
3
O
30
10
IBM
54
3
PNC
49
3
CMS
60
2
KLAC
59
3
WHR
64
2
NTAP
60
2
MAC
54
3
APA
35
3
PSX
27
2
YUM
43
3
EQT
48
6
MHK
27
2
FFIV
67
3
QCOM
59
3
MKC
53
2
FRT
39
3
SRE
47
7
DOV
50
2
FAST
44
3
O
30
10
IBM
54
3
PNC
49
3
CMS
60
2
Financhill
Back

Evoke Pharma Stock Price Chart

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
Sell
48

EVOK
Evoke Pharma

Last Price:
$4.89
Seasonality Move:
1.96%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • The current trend is moderately bullish and EVOK is experiencing slight selling pressure.

Evoke Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.85 Buy
20-day SMA: 4.5 Buy
50-day SMA: 4.96 Sell
200-day SMA: 5.56 Sell
8-day EMA: 4.83 Buy
20-day EMA: 4.69 Buy
50-day EMA: 4.8 Buy
200-day EMA: 6.65 Sell

Evoke Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 53.71 Buy
Chaikin Money Flow: -4088 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.17 - 4.83) Buy
Bollinger Bands (100): (4.26 - 5.52) Buy

Evoke Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Evoke Pharma Stock

Is Evoke Pharma Stock a Buy?

  • Evoke Pharma share price is 4.90 while EVOK 8-day simple moving average is 4.85, which is a Buy signal.
  • The stock price of EVOK is 4.90 while Evoke Pharma 20-day SMA is 4.50, which makes it a Buy.
  • Evoke Pharma 50-day simple moving average is 4.96 while EVOK share price is 4.90, making it a Sell technically.
  • EVOK stock price is 4.90 and Evoke Pharma 200-day simple moving average is 5.56, creating a Sell signal.

EVOK Technical Analysis vs Fundamental Analysis

Sell
48
Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy or a Sell?

  • Evoke Pharma stock is rated a Sell
    The current Evoke Pharma [EVOK] share price is $4.90. The Score for EVOK is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.

Evoke Pharma Stock Info

Market Cap:
7.3M
Price in USD:
4.90
Share Volume:
8.8K

Evoke Pharma 52-Week Range

52-Week High:
14.04
52-Week Low:
3.54
Sell
48
Evoke Pharma (EVOK) is a Sell

Evoke Pharma Share Price Forecast

  • What is the Evoke Pharma stock price today?
    The Evoke Pharma stock price is 4.90 USD today.
  • Will EVOK stock go up or go down?
    Evoke Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Evoke Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Evoke Pharma is overvalued.

Is Evoke Pharma Stock a Buy?

  • Evoke Pharma share price is 4.90 while EVOK 8-day exponential moving average is 4.83, which is a Buy signal.
  • The stock price of EVOK is 4.90 while Evoke Pharma 20-day EMA is 4.69, which makes it a Buy.
  • Evoke Pharma 50-day exponential moving average is 4.80 while EVOK share price is 4.90, making it a Buy technically.
  • EVOK stock price is 4.90 and Evoke Pharma 200-day simple moving average is 6.65, creating a Sell signal.

Fundamental Analysis of Evoke Pharma

Is Evoke Pharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

Technical Analysis of Evoke Pharma

Should I short Evoke Pharma stock?

* Evoke Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.